Lexaria Bioscience LEXX
NASDAQ LEXX
$3.09 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Amortization - Intangibles (2021)

Updated

Lexaria Bioscience's Amortization - Intangibles was $1,601 in fiscal Q4 2021 (quarter ended Aug 31, 2021), down 51.7% from the prior quarter.

Analysis

Lexaria Bioscience (LEXX) Amortization - Intangibles (2021) Analysis & Trends

For FY2021 (ended Aug 31, 2021), Amortization - Intangibles at Lexaria Bioscience came in at $10,926, up 466.7% from FY2020.

  • In earlier fiscal years, Amortization - Intangibles was $1,928 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lexaria Bioscience 3.26 Mn -12.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2021 1,601.00
May 31, 2021 3,315.00
API Access

Lexaria Bioscience Amortization - Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=LEXX&period=max&api_key=YOUR_API_KEY